摘要 |
<p>The present disclosure includes biomarkers, methods, devices, reagents, systems, and kits for the detection and diagnosis of cancer. In one aspect, methods are provided for diagnosing mesothelioma where the methods include detecting, in a biological sample, at least one biomarker value corresponding to at least one biomarker selected from the biomarkers provided in Table 1, wherein an individual is classified as having mesothelioma, or the likelihood of an individual having mesothelioma is determined, based on the at least one biomarker value. In another aspect, methods are provided for diagnosing cancer generally where the methods include detecting, in a biological sample at least one biomarker value corresponding to at least one biomarker selected from the biomarkers provided in Table 17, wherein an individual is classified as having cancer generally, or the likelihood of an individual having cancer is determined, based on the at least one biomarker value.</p> |
申请人 |
SOMALOGIC, INC. |
发明人 |
OSTROFF, RACHEL, M.;STEWART, ALEX, A., E.;WILLIAMS, STEPHEN, ALARIC;BRODY, EDWARD, N.;NIKRAD, MALTI;RIEL-MEHAN, MICHAEL |